Pretreatment with tyrosine kinase inhibitors partially attenuates ischemic preconditioning in rat hearts

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 275, Issue 6 44-6, 1998, Pages

  Fryer, Ryan M ^a   Schultz, Jo El J ^a   Hsu, Anna K ^a   Gross, Garrett J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Daidzein; Genistein; Lavendustin A

Indexed keywords

GENISTEIN; LAVENDUSTIN A; PROTEIN TYROSINE KINASE INHIBITOR;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032447141     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1998.275.6.h2009     Document Type: Article

References (26)

1. Akiyama, T., J. Ishida, S. Nakagawa, H. Ogawara, S. Watanabe, N. Itoh, M. Shibuya, and Y. Fukami. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262: 5592-5595, 1987.
2. Akiyama, T., and H. Ogawara. Use and specificity of genistein as inhibitor of protein-tyrosine kinases. Methods Enzymol. 201: 362-371, 1991.
3. Baines, C., L. Wang, M. Cohen, and J. Downey. Protein tyrosine kinase is downstream of protein kinase C for ischemic preconditioning's anti-infarct effect in the rabbit heart. J. Mol. Cell. Cardiol. 30: 383-392, 1998.
4. Bogoyevitch, M., P. Parker, and P. Sugden. Characterization of protein kinase C isotype expression in adult rat heart. Circ. Res. 72: 757-767, 1993.
5. Gray, M., J. Karliner, and D. Mochly-Rosen. A selective ε-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J. Biol. Chem. 272: 30945-30951, 1997.
6. Gross, G., and J. Auchampach. Blockade of the ATP-sensitive potassium channels prevents myocardial preconditioning. Circ. Res. 70: 223-233, 1992.
7. Imagawa, J., G. Baxter, and D. Yellon. Genistein, a tyrosine kinase inhibitor, blocks the "second window of protection" 48 h after ischemic preconditioning in the rabbit. J. Mol. Cell. Cardiol. 29: 1885-1893, 1997.
8. Klein, H., S. Puschmann, J. Schaper, and W. Schaper. The mechanism of the tetrazolium reaction in identifying myocardial infarction. Virchows Arch. 393: 287-297, 1981.
9. Kukreja, R., and Y. Qian. Tyrosine kinase pathway is involved in ischemic preconditioning in rat heart (Abstract). J. Mol. Cell. Cardiol. 29: A230, 1997.
10. Liu, G., J. Thorton, D. VanWinkle, A. Stanley, R. Olsson, and J. Downey. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit hearts. Circulation 84: 350-356, 1991.
11. Liu, Y., and J. Downey. Ischemic preconditioning protects against infarction in rat heart. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H1107-H1112, 1992.
12. ATP currents in intact ventricular myocytes: implications for preconditioning. Am. J. Physiol. 273 (Heart Circ. Physiol. 42): H1637-H1643, 1997.
13. Maulik, N., M. Watanabe, Y. Zu, C. Huang, G. Cordis, J. Schley, and D. Das. Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett. 396: 233-237, 1996.
14. Murry, C., R. Jennings, and K. Reimer. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136, 1986.
15. Okajima, F., M. Akbar, M. Majid, K. Sho, H. Tomura, and Y. Kondo. Genistein, an inhibitor of protein tyrosine kinase, is also a competitive antagonist for P1-purinergic (adenosine) receptor in FRTL-5 thyroid cells. Biochem. Biophys. Res. Commun. 203: 1488-1495, 1994.
16. Onada, T., H. Iinuma, Y. Sasaki, M. Hamada, K. Isshiki, H. Naganawa, and T. Takeuchi. Isolation of a novel tyrosine kinase inhibitor, lavendustin A, from Streptomyces griseolavendus. J. Nat. Prod. 52: 1252-1257, 1989.
17. Paillart, C., E. Carlier, D. Guedin, B. Dargent, and F. Couraud. Direct block of voltage-sensitive sodium channels by genistein, a tyrosine kinase inhibitor. J. Pharmacol. Exp. Ther. 280: 521-526, 1997.
18. Ping, P., J. Zhang, Y. Qiu, X. Tang, S. Manchikalapudi, X. Cao, and R. Bolli. Ischemic preconditioning induces selective translocation of protein kinase C isoforms ε and η in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ. Res. 81: 404-414, 1997.
19. Schott, R., S. Rohmann, E. Braun, and W. Schaper. Ischemic preconditioning reduces infarct size in swine myocardium. Circ. Res. 66: 1133-1142, 1990.
20. ATP channels. Am. J. Physiol. 274 (Heart Circ. Physiol. 43): H909-H914, 1998.
21. ATP channel antagonist, 5-hydroxydecanoate, blocks ischemic preconditioning in the rat heart. J. Mol. Cell. Cardiol. 29: 1055-1060, 1997.
22. Schultz, J., E. Rose, Z. Yao, and G. Gross. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H2157-H2161, 1995.
23. Schultz, J., Z. Yao, I. Cavero, and G. Gross. Glibenclamide-induced blockage of ischemic preconditioning is time dependent in intact rat heart. Am. J. Physiol. 272 (Heart Circ. Physiol. 41): H2607-H2615, 1997.
24. Speechly-Dick, M., M. Mocanu, and D. Yellon. Protein kinase C: its role in ischemic preconditioning in the rat. Circ. Res. 75: 586-590, 1994.
25. + channel blocker. Circulation 90: 700-705, 1994.
26. Vahlhaus, C., R. Schulz, H. Post, J. Rose, and G. Heusch. Prevention of ischemic preconditioning only by combined inhibition of protein kinase C and protein tyrosine kinase in pigs. J. Mol. Cell. Cardiol. 30: 197-209, 1998.